AstraZeneca Introduces At-Home FluMist Nasal Spray for Convenient Flu Vaccination
AstraZeneca's FluMist, a nasal spray flu vaccine, is now available for self-administration at home in 34 US states, aiming to improve vaccination rates by offering a convenient, needle-free option for adults and children, with FDA approval and insurance coverage.